toluenesulfonic acid (ZG2001)
/ Suzhou Zelgen
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 06, 2024
A Study of ZG2001 in Participants With KRAS Mutated Advanced Solid Tumours
(clinicaltrials.gov)
- P1/2 | N=110 | Recruiting | Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Not yet recruiting ➔ Recruiting | Initiation date: Feb 2024 ➔ Aug 2023
Enrollment open • Metastases • Trial initiation date • Colorectal Cancer • Gastrointestinal Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor
February 01, 2024
A Study of ZG2001 in Participants With KRAS Mutated Advanced Solid Tumours
(clinicaltrials.gov)
- P1/2 | N=110 | Not yet recruiting | Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
New P1/2 trial • Colorectal Cancer • Gastrointestinal Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1